McCarty T M, Kuhn J A, Williams W L, Ellenhorn J D, O'Brien J C, Preskitt J T, Lieberman Z H, Stephens J, Odom-Maryon T, Clarke K G, Wagman L D
Department of Surgery, City of Hope National Medical Center, Duarte, California 91010, USA.
Ann Surg Oncol. 1997 Jul-Aug;4(5):403-8. doi: 10.1007/BF02305553.
Locally advanced thyroid cancer invading the tracheal cartilage represents a difficult treatment dilemma during thyroidectomy.
A retrospective chart review was performed to determine the results of laryngotracheal resection or tracheal cartilage shave with adjuvant radiotherapy in patients with locally advanced thyroid cancer invading the upper airway.
Of 597 patients undergoing thyroidectomy for thyroid cancer, 40 were found to have laryngotracheal invasion. Thirty-five patients with superficial invasion underwent cartilage shave procedures with adjuvant radiotherapy; five with full-thickness invasion underwent radical resection, including tracheal sleeve resection (n = 3) or total laryngectomy (n = 2). Histologic subtypes included papillary (n = 32), follicular (n = 2), Hurthle cell (n = 1), medullary (n = 3), and anaplastic (n = 2). Of the cartilage shave group, 25 are currently alive with no evidence of disease at a mean follow-up of 81 months (range 1-290). Six developed isolated local/regional recurrence and were managed with total laryngectomy (n = 1), tracheal resection (n = 1), cervical lymphadenectomy (n = 1), or repeat radiotherapy (n = 3). All six patients remain free of disease at a mean follow-up of 5 years. Of those who underwent initial laryngotracheal resection, four remain free of disease at a mean follow-up of 5 years. The rates of 10-year disease-free survival and overall survival for all patients were 47.9% (95% confidence interval [CI] 24.8, 71.0) and 83.9% (95% CI 70.3, 97.5), respectively.
These data suggest that adequate management of thyroid cancer with laryngotracheal invasion can be achieved with a more conservative surgical approach and adjuvant radiotherapy, reserving more radical resections for extensive primary lesions or locally recurrent disease.
局部晚期甲状腺癌侵犯气管软骨在甲状腺切除术中是一个棘手的治疗难题。
进行一项回顾性病历审查,以确定局部晚期甲状腺癌侵犯上呼吸道患者行喉气管切除或气管软骨刮除加辅助放疗的结果。
在597例行甲状腺癌甲状腺切除术的患者中,发现40例存在喉气管侵犯。35例浅表侵犯患者接受了软骨刮除术加辅助放疗;5例全层侵犯患者接受了根治性切除术,包括气管袖状切除术(n = 3)或全喉切除术(n = 2)。组织学亚型包括乳头状癌(n = 32)、滤泡状癌(n = 2)、嗜酸性细胞癌(n = 1)、髓样癌(n = 3)和未分化癌(n = 2)。在软骨刮除组中,25例患者目前存活,平均随访81个月(范围1 - 290个月)无疾病证据。6例出现孤立性局部/区域复发,分别接受了全喉切除术(n = 1)、气管切除术(n = 1)、颈部淋巴结清扫术(n = 1)或再次放疗(n = 3)。所有6例患者在平均随访5年时仍无疾病。在最初接受喉气管切除术的患者中,4例在平均随访5年时仍无疾病。所有患者的10年无病生存率和总生存率分别为47.9%(95%置信区间[CI] 24.8, 71.0)和83.9%(95% CI 70.3, 97.5)。
这些数据表明,对于侵犯喉气管的甲状腺癌,采用更保守的手术方法和辅助放疗可实现充分治疗,对于广泛的原发性病变或局部复发性疾病则保留更根治性的切除术。